Etonogestrel may sound like the name of an exotic bird species, but it's actually the active ingredient in one of the latest pharmaceutical products at the center of product liability litigation – NuvaRing. It is part of a class of  synthetic hormones (that is, hormone analogues that were developed in a laboratory) first created in Germany in the late 1930s.